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ABSTRACT OF THESIS

INCREASE OF BASAL OXIDATIVE STRESS LEVELS AND IMPAIRMENT OF HEME
OXYGENASE-1/BILIVERDIN REDUCTASE POST-TRANSLATIONAL MODIFICATION
BY THE DEFECT OF PARKINSON-RELATED GENE OF PINK1

Parkinson disease (PD) is the most common movement disorder and the
second most common neurodegenerative disease. PINK1, PTEN-induced kinase
1, functions as a serine/threonine kinase as well as a protector of mitochondrial
function. Mutations in PINK1 gene result in either mitochondria dysfunction or
disruption of kinase signaling pathways involved in the pathogenesis of PD.
In this thesis, oxidative stress levels were examined in the brain of PINK1
knockout mice, and also how heme oxygenase-1 and biliverdin reductase are
affected in brain of PINK1 knockout mice. In addition, posttranslational
modifications are a way to control the behavior of proteins, so posttranslational
modifications of the brain of PINK1 knockout mice, including both oxidative
modification and phosphorylative modification, were examined.

Keywords: Parkinson disease (PD), PTEN-induced putative kinase 1 (PINK1),
Biliverdin reductase (BVR), Oxidative stress, Posttranslational modification
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Chapter 1.

Introduction

The studies presented in this thesis gained insight into the role of oxidative
stress, levels of heme oxygenase-1/biliverdin reductase (HO-1/BVR) along with
post-translational modifications of BVR in the brain of PINK1 knockout mice to
explore possible pathogenic mechanisms of Parkinson Disease (PD). Currently,
there are about 6.3 million people worldwide suffered from PD, and this number
will increase to 8.7 to 9.3 million by 2030 according to the report from European
Parkinson’s Disease Association. Therefore, the study of PD associated gene,
PINK1, would be meaningful.
As we known, oxidative stress is an imbalance between the levels of
antioxidants

and

oxidants

which

contributes

to

the

pathogenesis

of

neurodegenerative diseases (Butterfield and Kanski 2001). Normally, antioxidant
system helps to neutralize oxidative insults. However, it could be not sufficient to
compensate the excess amount of oxidative stress when homeostasis in cells is
disrupted. Oxidative damage can be quantified by protein carbonylation, lipid
peroxidation, and protein nitration (Dalle-Donne, Rossi et al. 2003, Dalle-Donne,
Rossi et al. 2006). PINK1 is a serine/threonine protein kinase served as a
protector of mitochondria. Dysfunction of PINK1 protein disrupts mitochondrial
function and results in the formation of oxidative stress (Gautier, Kitada et al.
2008). The HO-1/BVR system plays a key role in the response to cell stress.
Heme oxygenase-1 (HO-1) is an enzyme that converts heme b to biliverdin.
Biliverdin subsequently is converted to bilirubin by biliverdin reductase (BVR).
Bilirubin is considered as a strong antioxidant protecting cells from oxidative
damage (Barone, Di Domenico et al. 2014).
In addition, oxidative translational modification of a specific protein shows
how it responds to oxidative stress, while phosphorylation translational
modification regulates the activity of this protein. This thesis also provides
evidence that the potential antioxidant characteristic of BVR keeps oxidative
modification of BVR back to normal level. On the other hand, increases of BVR
1

phosphoserine and phosphothreonine in the brain of PINK1 knockout mice
conceivably is a compensatory response to the elevated oxidative stress,
potentially activating the reductase function of BVR. Analysis of the PINK1
knockout brain will provide further understanding of PD.
To summarize, this thesis research has used the brain of PINK1 knockout
mice to achieve the following goals:
1. To provide an evidence that oxidative stress plays an important role in
PINK1 deficiency cells.
2. To verify the efficiency of HO-1/BVR antioxidant system in the cells
suffered from oxidative stress.
3. To determine the oxidative/nitrosative stress-induced modification and
phosphoserine and phosphothreonine of BVR.
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Chapter 2.

2.1

Background

Oxidative Stress

2.1.1 Overview of Oxidative Stress
Oxidative stress (OS) is defined as an imbalance between the level of
antioxidants and oxidants favoring the latter when physiological homeostasis is
disrupted. OS has been reported to play a prominent role in the pathogenesis of
neurodegenerative disorders including Parkinson’s disease (PD) (Jenner, Dexter
et al. 1992, Jenner 2003). Brain is one of the most vulnerable organs to oxidative
damage since it has a high consumption of oxygen, high number of mitochondria
that leak superoxide free radicals, and is rich in polyunsaturated fatty acids
(PUFAs) that can be attacked by free radicals easily. Moreover, brain
concentrates metal ions suggesting a strong possibility to contribute to oxidative
stress in age-related neurodegenerative diseases (Bush 2000). Excess iron
levels in the substantia nigra in PD leads to enhanced production of free radicals
and eventually cause oxidative events (Hirsch, Brandel et al. 1991). Low level of
antioxidants in brain is another reason to cause oxidative damage in brain. In PD,
reduced glutathione (GSH) levels are decreased while oxidants make more
negative effects on brain (Sofic, Lange et al. 1992).
Within cells oxidative damage to proteins, lipids and DNA is caused by the
excess production of oxidants even though they serve as second messengers
and activators of signaling cascades with a basal level (Suzuki, Forman et al.
1997, Goldstein, Mahadev et al. 2005). Oxidants can be either free radical or
non-radical molecules and either reactive oxygen species (ROS) or reactive
nitrogen species (RNS). In general, the majority of ROS/RNS are derived from
superoxide anions (O2.-), which are the products of O2 and electron by
transferring electron leaked from the ETC to ground state O2 (reaction 1)
(Turrens 2003). However, ROS/RNS also come from other sources, such as
environmental toxins, ultraviolet light, and cellular processes (Mena, Ortega et al.
2009).
3

O2 + e-

O2.-

(reaction 1)

Furthermore, O2.- readily reacts with other reactive species when
antioxidants are deficient to produce more detrimental ROS/RNS, such as
hydroxyl (OH.), hydrogen peroxide (H2O2), hypochlorous acid (HOCl) and
nitrogen dioxide (NO2.). Some of superoxide anions can be dismutated to
hydrogen peroxide (H2O2) by superoxide dismutase (SOD) (reaction 2).
Subsequently, newly formed H2O2 will react with excess superoxide anion
(reaction 3). It is noteworthy to indicate that the partially reduced product, OH., is
the most reactive and unstable form of ROS which can also be generated by the
other two pathways (Turrens 2003). One of which is via Fenton reaction using
reduced metal ions, such as iron and copper, released by some metal-binding
proteins. (reaction 4-5) (Berlett and Stadtman 1997, Barnham, Masters et al.
2004).
O2.-

H2O2 + H2O

(reaction 2)

OH- + O2 + OH.

(reaction 3)

H2O2 + Fe2+

OH- + Fe3+ + OH.

(reaction 4)

H2O2 + Cu+

OH- + Cu2+ + OH.

(reaction 5)

2H2O2 + 2O2.-

SOD

The third pathway of OH. formation is through the presence of nitric oxide
(NO.) and the hemolysis of ONOOH. The product of reaction 6, peroxynitrite
(ONOO-), is another strong oxidant. This is also a pathway to generate some
prominent RNS (reaction 6-8) (Radi 2004, Goldstein, Lind et al. 2005). A more
detailed mechanism for reaction of NO. with O2.- is shown in section 2.1.4.
NO. + O2.ONOO- + H+
ONOOH

ONOOONOOH
NO2. + OH.

(reaction 6)
(reaction 7)
(reaction 8)

OH., as a secondary oxidizing species, is quite damaging. It is able to
interact with almost any other free radical or nonradical species to cause post
4

translational modifications (PTM) such as protein oxidation, lipid peroxidation. At
the same time, the other product, NO2., is involved in protein nitration. Thereby,
oxidative damage has been amplified. In addition, when NO. is consumed to form
ONOO-, NO. is depleted. However, NO. is important to many physiological
processes including, among others, vasodilation and neurotransmission (Belvisi,
Stretton et al. 1992, Steinberg, Brechtel et al. 1994). As we can see, cells
undergo oxidative stress even if slight overabundance of ROS/RNS. The results
of oxidative damage usually cause protein structural alteration, enzyme inhibition,
and the impairment of regulatory functions.

2.1.2 Protein carbonylation
The presence of protein carbonyl groups in brain proteins is one of the
most common features in neurodegenerative disease. Because protein carbonyl
groups form in early stages of these disorders and are relative stable, these are
commonly used as an index of oxidative stress. There are five pathways to
generate protein carbonyl groups. Carbonyl derivatives are firstly yielded by
oxidation of the side-chains of several amino acids especially for proline, arginine,
lysine, and threonine residues (Table 2.1) (Dalle-Donne, Rossi et al. 2003).
Cleavage of the peptide bond by either diamide or α-amidation pathways is the
second way to form CO double bonds (Figure 2.1) (Berlett and Stadtman 1997,
Stadtman and Levine 2003). Protein carbonyl groups can be generated through
oxidation of glutamyl side chains (Figure 2.2) (Berlett and Stadtman 1997,
Stadtman and Levine 2003). Protein carbonyls can also react for processes of
glycoxidation (Stadtman and Levine 2003). Lastly, protein carbonyl groups result
from protein addition by a product of lipid peroxidation, HNE, (discussed later).

5

Table 2.1 Carbonyl groups modified amino acids
Amino acid

Carbonyl derivatives

Proline

2-Pyrrolidone

Arginine

Glutamic semialdehyde

Lysine

Aminoadipic semialdehyde

Threonine

2-amino-3-keto butyric acid

6

Structure

Figure 2.1 Cleavage of the peptide bond by diamide or α-amidation

Figure 2.2 Oxidation of glutamyl residues to form protein carbonyl groups

7

As an oxidative damage, protein carboxylation disrupts tertiary structure of
protein leading to unfolding or conformational changes. The amino acid on
protein become more polar with the introduction of protein carbonyl groups,
thereby exposing hydrophobic residues to the aqueous environment and losing
functions (Dalle-Donne, Aldini et al. 2006). Increased protein carboxylation,
coupled with less efficiency of proteolysis may result in the aggregates of
misfolded proteins associated diseases including PD. Protein carbonyl levels can
be quantified by immunohischemistry after being derivatized with 2,4dinitrophenylhydrazine (DNPH) to form the protein hydrazone (Dalle-Donne,
Rossi et al. 2003).

2.1.3

Lipid peroxidation
Lipids are the most common components of biological membrane. Lipids

play an important role in fluidity, flexibility, and selective permeability. Even small
changes of lipid may greatly alter the physiological properties of the membrane,
contributing to the pathology of diseases. Lipid peroxidation is one of the
outcomes of oxidative stress and is a source to spread and amplify free radical
reaction (Gutteridge 1995). Among all kinds of lipids, phospholipid is the most
susceptible one to undergo this process not only because of high level of
polyunsaturated fatty acids (PUFAs) but also because of a relative easier
accessibility to free radicals. Generally, lipid peroxidation consists of three stages:
initiation, propagation, and termination. In the initiation stage, allylic hydrogen on
acyl chains of phospholipids is easily abstracted by free radicals such as OH.,
RO., ROO. to form a carbon center lipid radical (L.). The lipid radical
subsequently reacts with oxygen, producing a lipid peroxyl radical (LOO.). This
radical is able to abstract another allylic hydrogen from a different PUFA to
produce a lipid hydroperoxide (LOOH) and a new lipid radical (L.), which
continuously reacts with oxygen molecular. This process is a chain reaction
called propagation. As a result, more and more LOOH are formed. In the
presence of reduced metal ions, LOOH can be reduced to phospholipid alkoxyl
radical (LO.), and then break down to reactive aldehyde products. When the
8

concentration of lipid radical is high enough, the chain reaction stops by collision
of two radicals (reactions 9-12) (Catala 2006, Catala 2009). This complex
process modifies physical properties of membrane function including change in
membrane fluidity, membrane permeability, and membrane protein activity.
LH + X.

L. + XH

(reaction 9)

L. + O2

LOO.

(reaction 10)

LOO. + LH

LOOH + L.

LOO. + LOO.

Non-radical + O2

(reaction 11)
(reaction 12)

4-Hydroxynonenal (HNE), a major aldehyde product of lipid peroxidation,
has been recognized as an indicator of lipid peroxidation. HNE is involved in
apoptosis, damage of proteasomal function, and the alteration of signal
transduction, contributing to neurodegenerative diseases (Kruman, BruceKeller
et al. 1997, Ferrington and Kapphahn 2004). The γ carbon of aldehyde group is
electron deficient so that be able to react with nucleophilic groups such as
sulfhydryl groups, imidazole groups, and amino groups. Therefore, HNE reacts
with cysteine, histidine, and lysine by Michael addition to produce reactive
aldehyde derivatives (Table 2.2) (Esterbauer, Schaur et al. 1991). This is another
way to generate protein carbohydrate derivatives. Protein polarities and
structures are altered because of the products of lipid peroxidation. As a
consequence, this whole process alters lipid-lipid and lipid-protein interactions as
well as membrane functions.
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Table 2.2 HNE adduct of Histidine, Lysine, and Cysteine
Amino Acid

HNE

Protein–alkenal Adducts

Histidine

Lysine

Cysteine

2.1.4

Protein nitration
Similar to ROS, protein nitration caused by toxic RNS leads to oxidative

damage to proteins as well. Nitric oxide (NO.) is regarded as an initial source of
this process, which is able to produce other relative reactive intermediates.
Normally, NO. is involved in cell signaling, vasodilation, and immune response
(Drew and Leeuwenburgh 2002). However, excess nitric oxide can participate as
a cytotoxin in cellular. NO. is formed by nitric oxide synthase (NOS) family. NOS
catalyzes the conversion of L-arginine to L-citrulline and forms NO. as a
byproduct (Figure 2.3). The NOS family insists of three distinct isoforms: Ca2+10

dependent neuronal NOS (nNOS), Ca2+-dependent endothelial NOS (eNOS),
and Ca2+-independent inducible NOS (iNOS), which play different roles in
different organs (Alderton, Cooper et al. 2001, Drew and Leeuwenburgh 2002).

Figure 2.3 Formation of nitric oxide (NO.) by nitric oxide synthase (NOS)

Mostly, nitric oxide mediates protein nitration on two aspects. It also
triggers S-nitrosylation of reduced cysteine residues. Oxygen that is required in
the S-nitrosylation is converted to superoxide (Gow, Buerk et al. 1997,
Broniowska and Hogg 2012). Most of superoxide in vivo is dismutated by SOD.
However, the reaction of HO-O. with NO. has a larger rate constant than with
SOD. Therefore, NO. competes SOD for HO-O. to form peroxynitrite and nitrogen
dioxide (reaction 13-16) (Radi 2004).
Protein-SH + NO.
Protein-S-N.-OH + O2
HO-O.

SOD

HO-O. + NO.

Protein-S-N.-OH
Protein-S-NO + HO-O.
H2O2 + O2

(reaction 14)
(reaction 15)

NO2. + OH.

ONOOH

(reaction 13)

(reaction 16)

The most pronounced modification caused by nitric oxide is the formation
of 3-nitrotyrosine (3-NT). Nitric oxide is first converted to a very reactive oxidant
peroxynitrite anion (ONOO-). The latter has been observed to react with CO2 to
form ONOOCOO-, which subsequently breaks down into nitrogen dioxide (NO2.)
and carbonate radical (CO3.-) (reaction 17-18). With the presence of CO3.-, tyrosyl
radical is generated by losing an electron from tyrosine. Ultimately, NO2. attaches
to tyrosyl radical to yield 3-NT (Figure 2.4). This is a radical-radical reaction,
11

peroxynitrite itself cannot react with tyrosine directly. Site specific nitration of
tyrosine causes steric restriction so that changes the function of protein by
lowering pKa of hydroxyl group and providing steric hindrance, thereby inhibiting
tyrosine phosphorylation (Gow, Duran et al. 1996, Di Stasi, Mallozzi et al. 1999,
Radi 2004). Nitrated mitochondrial proteins contribute to oxidative damage.
Therefore, it is important to measure 3-NT level as an index to evaluate protein
nitration.
NO. + O2.-

ONOO-

ONOO- + CO2

(reaction 17)

ONOOCOO-

NO2. + CO3.

Figure 2.4 Formation of 3-nitrotyrosine (3-NT)
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(reaction 18)

2.2

Parkinson Disease

2.2.1 Parkinson Disease Overview
PD is the second most common neurodegenerative disease after
Alzheimer disease and the most common movement disorder (Giasson, Duda et
al. 2002, Maragakis and Rothstein 2006). PD is characterized by progressive
loss of dopaminergic neurons in the substantia nigra. The clinical symptoms of
PD include muscle rigidity, tremor, a slowing of physical movement
(bradykinesia), even a loss of physical movement (akinesia) (Fahn 2003,
Thomas and Beal 2007). PD usually affects people over the age of 50 with a
current estimation of 1.5 million in the United States. PD can be either sporadic
or familial. Although most cases of PD are the sporadic form, studies of genes
linked to rare familial disease help people better understand the mechanism of
PD and provide the targets for therapeutic intervention.
Several genes, including α-synuclein, parkin, DJ-1, UCHL-1, PINK1 and
LRRK2, have been clearly identified to be associated with PD in both sporadic
and familial forms. All these five genes play prominent roles in protecting neurons
from

mitochondrial

dysfunction,

oxidative

damage,

abnormal

protein

accumulation and protein phosphorylation (Thomas and Beal 2007). α-synuclein
is a presynaptic protein to play an important role in neurotransmission (Yavich,
Tanila et al. 2004). Mutations or oxidation of α-synuclein enhance α-synuclein
aggregation. The abnormal protein aggregation, termed Lewy bodies (LBs), is
the most typical hallmark of PD brain (Spillantini, Crowther et al. 1998). Parkin
functions as an E3 ubiquitin protein ligase catalyzing transfer of ubiquitin to
cellular proteins for subsequent proteolysis and protecting dopamine neurons
(Walden and Martinez-Torres 2012). DJ-1, known as an antioxidant, is able to
serve as a scavenger of reactive oxygen species (ROS) and an activator of
glutamyl cysteine ligase. Moreover, α-synuclein aggregation and subsequent
death can be blocked by DJ-1 (Shendelman, Jonason et al. 2004, Zhou and
Freed 2005). UCHL-1 plays an important role in the ubiquitin proteasome
pathway. It helps to hydrolyze peptide ubiquitin bonds and generate ubiquitin
13

monomers for re-use. The I93M mutation of UCHL-1 was first discovered to
cause PD, whereas S18Y may reduce risk for PD by inhibiting ligase activity
(Healy, Abou-Sleiman et al. 2004). Both PINK1 and LRRK2 are mitochondrial
serine/threonine

protein

kinases,

protecting

mitochondrial

function.

The

mitochondrion, a critical target in PD, is impaired by mutations of any of above
genes, which might cause dysfunction in maintenance and survival of
dopaminergic neurons (Beal 2007).
Disrupted

mitochondrial

function

is

likely

to

decrease

oxidative

phosphorylation and decrease complex I activity in PD, resulting in ROS
formation, oxidative stress, and loss of ATP production. Increased oxidative
stress can induce overload function of the ubiquitin proteasomal system (UPS),
ultimately leading to irreversible cellular damage and death. In parallel, loss of
the mitochondrial membrane potential occurs. This leads to opening of the
mitochondrial permeability transition pore (mPTP), releasing of cytochrome c,
and activation of mitochondrial-dependent apoptosis (Abeliovich 2007). Growing
evidence shows that mitochondrial deficiency and oxidative stress play prominent
roles in PD pathogenesis.

2.2.2

PINK1 Involvement in PD
PINK1 (PARK6), PTEN-induced kinase 1, was identified in 2004 as the

second most genetic cause of recessively inherited early-onset parkinsonism
(Gandhi, Muqit et al. 2006, Ibanez, Lesage et al. 2006). PINK1 functions as a
serine/threonine kinase as well as a protector of mitochondrial function. The Cterminal domain of PINK1 mediates kinase function while the N-terminal
mitochondrial targeting motif helps to maintain mitochondrial function and
morphology. PINK1 is localized in the mitochondria membrane, can be found
throughout the body, and has a function in the whole brain not only in the
substantia nigra (Gandhi, Muqit et al. 2006). In brief, PINK1 protects neurons in
four pathways. Firstly, PINK1 phosphorylates TRAP1. Phosphorylated TRAP1 in
turn blocks generation of mitochondrial ROS and prevents release of cytochrome
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c from the mitochondrial intermembrane space into the cytoplasm (Plun-Favreau
and Hardy 2008). Secondly, PINK1 enhances phosphorylation of the
mitochondrial protease HtrA2. Activated HtrA2 then increases protease activity
and enhances resistance of cells to mitochondrial stress. Both these pathways
demonstrate a role for the kinase in maintenance of mitochondrial function and
prevention of stress-induced apoptosis. Thirdly, PINK1 is also able to interact
with Parkin and protect the mitochondria by either PI3-kinase/Akt pathway or
IKK/NF-κB signaling pathway. Parkin acts downstream of PINK1 indicating that
two genes might share a conserved genetic pathway. Overexpression of Parkin
can protect against the effect of PINK1 mutation. Lastly, PINK1 enhances the
activity of anti-apoptotic protein Bcl-2 to reduce apoptosis (Abeliovich 2007, PlunFavreau, Klupsch et al. 2007, Mills, Sim et al. 2008). Mutations in PINK1 gene
result in either mitochondria dysfunction or disruption of kinase signaling
pathways involved in the pathogenesis of PD. PINK1-deficient cells trigger
intrinsic mitochondrial apoptosis as stated in the last section. Mutations of PINK1
also alter mitochondrial integrity and proliferation. Proliferation of mitochondria
may occur to compensate for dysfunctional mitochondria induced by oxidative
stress to produce more ATP needed for cell survival. However increased
numbers of mitochondria will in turn cause extra ROS, which means more
oxidative damage to cells (Wood-Kaczmar, Gandhi et al. 2008). In the current
thesis research, PINK1 knockout mice were used as a model to investigate PD.

2.3

Heme oxygenase
Heme oxygenase (HO) is an enzyme responsible for degradation of heme

b to biliverdin, ferrous ion, and carbon monoxide (CO) (reaction 19). Heme b
comes from heme-containing proteins such as hemoglobin, myoglobin,
cyclooxygenase, etc. Biliverdin is a potential antioxidant which is immediately
converted to bilirubin by biliverdin reductase. Bilirubin has been known as a
powerful antioxidant. On the other hand, ferrous ion and CO would be toxic at
high concentrations. Accumulation of ferrous ion would lead to Fenton chemistry
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as mentioned in Section 2.1.1, even though some of ferrous ion can be
sequestered by ferritin. Therefore, excess of ferrous ion and CO may contribute
the pathology of Parkinson disease. Generally, heme oxygenase has two
isoforms: Heme oxygenase-1 (HO-1) and Heme oxygenase-2 (HO-2). HO-1 is an
inducible isoform that is upregulated by transcription factors in response to
inducers. Stress inducers can be numerous, such as oxidants, heavy metals,
hormones, etc. HO-2 is a constitutive isoform that is usually expressed at a low
level under physiological conditions. In addition, HO-1 has been observed to be
beneficial for learning ability (Chen, Huang et al. 2013).

(reaction 19)

2.4

Biliverdin reductase

2.4.1 Biliverdin reductase Regulation, and Reductase Activity
As mentioned above, biliverdin reductase (BVR) firstly was recognized as
a reductase that converts biliverdin to bilirubin (reaction 20). NADPH participates
this reaction under basic pH, whereas NADH is used under acidic conditions.
Bilirubin is the final product from heme degradation which is an antioxidant
capable of ROS scavenge. As a response to the increase level of heme
degradation and HO-1 expression, the conversion of biliverdin to bilirubin would
increase subsequently. However, organisms are able to balance these changes.
Extra bilirubin inhibits BVR activity to accumulate biliverdin. The negative
feedback inhibits HO-1 activity, leading HO-1/BVR system to return to normal
(Kutty and Maines 1981, Kutty and Maines 1984).
(reaction 20)
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2.4.2 Biliverdin reductase kinase activity, and the role in cell signaling
Biliverdin reductase recently has been also identified as one of a rare
group of dual-specificity kinases that has the ability to autophosphorylate, or
phosphorylate serine/threonine and tyrosine residues (Hunter and Cooper 1985).
Different mammalian species share more than eighty percent of BVR gene
sequence (Maines 2005). Traditionally, the sequence consists of catalytic domain
and regulatory domain. In the recent years, human biliverdin reductase (hBVR)
has been studied extensively. BVR is identified to have potential functions in the
insulin signaling pathway. Insulin signaling pathway starts with insulin receptor
(IR) which is a protein tyrosine kinase consisting of α-subunit and β-subunit
connected by disulfide bonds. The α subunit has a binding site to insulin or
insulin growth factor 1 (IGF-1). Insulin/IGF-1 attaches to the α-subunit of IR and
tyrosine phosphorylation of β-subunit activates IR. BVR is activated by
phosphorylation. In the insulin signaling pathway, BVR is upregulated by insulin
receptor tyrosine kinase and negatively affects glucose uptake. The subsequent
phosphorylated BVR effectively competes with insulin receptor kinase for
serine/threonine phosphorylation of insulin receptor substrate 1 (IRS-1) (LernerMarmarosh, Shen et al. 2005, Maines 2005). Then two major arms of signaling
pathways are activated: mitogen-activated protein kinase (MAPK) and PI3K
cascades (Figure 2.5). Except for kinase acitivity, hBVR also functions as a
transcriptional factor in insulin signaling pathway (Maines 2007).
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Figure 2.5 Function of BVR as a kinase in the IR/IGF-1 signaling cascade
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2.5

Hypothesis
Since oxidative stress contributes to neurodegenerative disease and

PINK1 knockout mice is a model of Parkinson’s disease, there will be an
increase level of oxidative stress observed in the brain of PINK1 knockout mice.
The increased level of oxidative stress is able to induce overexpression of heme
oxygenase 1 and biliverdin reductase with aid of the transcription factor Nrf2.
With the enhanced expression of BVR, increased level of biliverdin will result
which

scavenges

ROS/RNS.

Therefore,

the

oxidative

posttranslational

modification of BVR can return to normal. Additionally, biliverdin reductase
phosphoserine and phosphothreonine in the brain of PINK1 knockout mice may
be increased responding to the elevated oxidative stress.
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Chapter 3.

3.1

Materials and Experimental Procedures

Chemicals and Materials
2, 4-Dinitrophenylhydrazine (DNPH), primary Rb x DNP antibody, re-blot

plus strong antibody stripping solution were purchased from Chemicon
(Temecula, CA). Protease inhibitors, primary anti-biliverdin reductase and antinitrotyrosine antibodies, secondary anti-rabbit IgG alkaline phosphatase and antitubulin antibodies were purchased from Sigma-Aldrich (St. Louis, MO). Primary
anti-HNE antibody was purchased from Alpha Diagnostic (San Antonio, TX).
Primary anti-phosphothreonine, anti-phosphoserine antibodies were obtained
from Invitrogen (Camarillo, CA). Secondary anti-rabbit IgG horseradish
peroxidase, cydye3 and cydye5 were purchased from GE healthcare (Pittsburgh,
PA). BCA protein estimation assay kit, BCIP/NBT color development substrate
(5-bromo-4-chloro-3-indolyl-phosphate/nitro blue tetrazolium) were purchased
from Pierce (Rockford, IL). Polyacrylamide gels, Precision plus proteinTM all blue
standards, XT MES electrophoresis running buffer, nitrocellulose membranes,
and ClarityTM western ECL substrate were got from Bio-Rad (Hercules, CA).

3.2

Animals
In this work, whole brain samples of PINK1 knockout mice (male, n=6) and

age-matched control mice (male, n=6) were obtained from our collaborator, Dr.
Hans Büeler, University of Kentucky. All mice were mixed background (C57BL/6
x 129/Sv). Generation of PINK1 knockout mice was described in a previous
publication (Akundi, Huang et al. 2011). Knockout and control mice were
euthanized at six months old. Brain tissues were isolated immediately and stored
at -80°C until use.
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3.3

Sample Preparation
Brain samples were homogenized using a glass mortar and pestle in

isolation buffer (pH 7.4, 300-500 µL for each sample) containing 0.32M sucrose,
2mM EDTA, 2mM EGTA, 20mM HEPES, 0.2mM PMSF, leupeptin (4µg/ml),
pepstatin (4µg/ml), aprotinin (5µg/ml), and phosphatase inhibitor cocktail (1:100).
After homogenization, tissues were transferred into a set of Eppendorf tubes.
Aliquot samples (200 µL) to another Eppendorf tube and each sample was
sonicated with a Fisher 550 sonic Dismembrator (Fischer Scientific, Pittsburgh,
PA) for 20s at 20% power. Then another 100 µL of isolation buffer was added.
Samples were centrifuged 10 min at 3000rpm, 4°C using a Hettich Mikro 22R
Microcentrifuge (Hettich, Beverly, MA) and all the supernatants were collected for
one-dimensional SDS-PAGE processing. Supernatants (100 µL) were transferred
into another set of tubes following the addition of 200 µL of isolation buffer, and
the tissues were saved for slot blotting. Sample concentrations were determined
by the Bicinchoninic Acid (BCA) protein estimation assay. All the samples were
stored at -80°C.

3.4

Bicinchoninic Acid (BCA) Protein Estimation Assay
All the protein concentrations in this study were determined using the BCA

protein estimation assay. This assay couples the reduction of Cu2+ to Cu1+ by
protein in an alkaline medium with the colorimetric detection of Cu1+ by BCA. The
BCA assay reagent is the mixture of reagent A (sodium carbonate, sodium
bicarbonate, bicinchoninic acid and sodium tartrate in 0.1 M sodium hydroxide)
and reagent B (4% cupric sulfate pentahydrate) in the ratio (49:1) freshly made
before the experiment. In the former reaction, which known as the Biuret reaction,
Cu2+ ions from reagent B are reduced by the presence of four amino acids
(cysteine, cystine, tryptophan and tyrosine) and peptide bonds (reaction 1). The
resultant Cu1+ ions subsequently react with two BCA molecules from reagent A to
generate purple colored complexes which exhibit a strong linear absorbance at
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562 nm (reaction 2). Protein concentration is directly proportional to the intensity
of absorbance.
Proteins (peptide bonds & amino acids) + Cu2+
Cu1+ + 2 Bicinchoninic Acid (BCA)

Cu1+

(reaction 1)

BCA-Cu1+ complex (purple-colored)

(reaction 2)
Each sample (2 µL) was pipetted along with in duplicate gradient
concentrations of standards, bovine serum albumin (BSA) into a 96-well
microplate (Evergreen Scientific, Los Angeles, CA); samples and standards were
diluted with the BCA assay reagent to make a final volume to 100 µL in each well;
the microplate was incubated for 15 min at 37 °C and gently rocked before
reading the absorbance in a μ-Quant UV plate reader (Bio-Tek, Winooski, VT).
Finally, the protein concentration follows was calculated using the Lambert-Beer
law.

3.5

Slot Blot Analysis Oxidative Stress

3.5.1 Slot Blot Technique
Slot blot, a microfraction of the dot blot technique, is a useful tool for the
detection of global levels of a protein modification such as protein carbonyl (PC)
or 3-nitrotyrosine (3-NT) with very small amount of samples required (< 1 µg).
Protein samples firstly are dissolved in SDS containing buffer, whereas PC later
needs to be incubated with DNPH before loading in duplicate on the
nitrocellulose membrane under vacuum. SDS imparts negative charges to
proteins. Therefore, positively charged nitrocellulose membrane is able to bind
proteins, but any uncharged materials will pass through the pores of
nitrocellulose membrane. The membrane is removed from the apparatus
followed by blocking with BSA and probing with specific primary and secondary
antibodies corresponding to a specific protein modification. With the colorimetric
development, spots are visualized and can be quantitated based on the intensity
using Image Lab software.
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3.5.1.1

Detection of Protein-Bound Carbonyls

Protein carbonyls are a global index of protein oxidation. Carbonyl groups
of protein except for the primary chain peptide bond carbonyls are derivatized by
DNPH

to

form

hydrazones

(Figure

3.1).

The

protein-bound

2,4-

dinitrophenylhydrazone can be attached to the primary antibody reorganizing the
hydrazone adduct. A secondary antibody coupled to alkaline phosphatase is
attached to the primary antibody, and the amount of primary antibody bound is
finally detected by BCIP/NBT color development substrate (5-bromo-4-chloro-3indolyl-phosphate/nitro blue tetrazolium).

Figure 3.1 Derivatization of protein carbonyls by DNPH

Each brain sample (5 µL) was derivatized at room temperature by
incubation with 5 µL of 12% SDS and 10 µL of 10mM DNPH solution in 2N HCl
for 20 min. The samples were then neutralized by adding 7.5 µL of neutralization
buffer. Derivatized samples were diluted with PBS to make a final concentration
of 1 µg/mL. Diluted samples (250 µL/well) were loaded in duplicate onto a
nitrocellulose membrane under vacuum pressure. Membrane was then incubated
in a blocking solution containing 750 mg BSA per 25 mL wash blot (35.2g NaCl,
1.77g NaH2PO4, 9.61g Na2HPO4, 1.5mL TWEEN, diluted to 4L with DI water) for
one and a half h to prevent non-specific binding of antibodies. Next the
membrane was incubated with a 1:100 dilution of rabbit polyclonal anti-DNP
primary antibody for 2 h. Blot was then rinsed three times, 5 min each in wash
blot, and subsequently incubated with 1:8000 dilution of anti-rabbit IgG-alkaline
23

phosphatase secondary antibody for exactly 1 h. After another three times, 5, 10,
10 min, respectively, washes, the membrane was colorimetrically developed and
dried overnight. The membrane was scanned on the second day using
ChemiDocTM MP Imaging System (Bio-Rad, Hercules, CA) and the bands were
quantified using Image Lab software.

3.6

One-Dimensional SDS-PAGE and Western Blotting
One-dimensional

sodium

dodecyl

sulfate

polyacrylamide

gel

electrophoresis (1D SDS-PAGE) is used to separate proteins based on their size,
shape and molecular weight. Prior to running the gel, 75 µg of each sample were
suspended in DI water and 4X SDS-sample buffer (5 µL) composed of 0.5 M Tris
(pH 6.8), 40% glycerol, 8% SDS, 20% β-mercaptoethanol, and 0.01%
bromophenol blue to make final volume 25 µL. SDS is able to coat proteins and
impart negative charges on proteins so that samples can migrate from the
negatively charged anode to the positively charged cathode under the influence
of a current. Samples were then denatured in boiling water for 5 min and cooled
immediately on ice before electrophoresis. Precision Plus Protein TM All Blue
Standards (5 µL) and the prepared samples were loaded in separate lanes on
12% Bis-Tris polyacrylamide gel using 1X XT MES as running buffer. The electric
field was initially set at 80 V for the first 8 min and increased to 120 V until the
blue line reached the bottom of the gel. Sample proteins were separated through
gel electrophoresis. The relative migration rate (Mr) depends on the resistance of
gel. Generally, larger proteins have higher resistance with lower Mr compared to
smaller proteins, though shape (i.e. cylindrical shaped) proteins migrate slower
than similar MW proteins of spherical shape.
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Figure 3.2 1D SDS-PAGE

Western blotting is used to immobilize proteins onto the nitrocellulose
membranes. The membranes can be easily incubated with antibodies of interests
to measure specific proteins or post-translational modifications of specific
proteins. In this study, this technique has been extensively used for the detection
of HNE-bound protein, protein-resident 3-NT, the expression of HO-1 and BVR,
and oxidative or phosphorylation post-translational modifications of BVR.
Through running a semi-dry Transfer Cell System (BioRad, Hercules, CA) at 1.0
A for 30 min, negatively charged proteins were transferred from the gel to the
positively charged nitrocellulose membrane. During transfer, the gel sandwich
was made from two thick filter papers, a nitrocellulose membrane, and the gel
was submerged in transfer buffer containing Tris-HCl, glycine, and methanol.
Methanol is present to prevent the gel from swelling. The membrane was then
incubated in a blocking solution for one and a half hours. Protein levels were
evaluated via incubating with primary antibodies of interest overnight. After three
5 min washes, samples were incubated with secondary antibodies for exactly 1 h.
The membrane was washed three times again, and finally developed using
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immunofluorescence or chemiluminescent techniques. The intensities of bands
were quantified by Image Lab analysis software.
1:1000 dilutions of primary anti-heme oxygenase-1 and anti-biliverdin
reductase antibodies, 1:5000 dilution of primary anti-HNE polyclonal antibody,
and 1:2000 dilution of rabbit polyclonal anti-3-NT primary antibody were used to
measure HO-1, BVR, protein-bound HNE, and protein-resident 3-NT levels,
respectively. Because immunofluorescence development was adopted, the blots
were then incubated with Cy5 anti-rabbit secondary antibody for 1 h in dark. For
loading controls, the blots were probed with primary anti-Tubulin antibody and
secondary Cy3 anti-mouse antibody.

3.7

Identification of Post-translational Protein Modifications Using
Immunoprecipitation Approaches
Immunoprecipitation (IP) is the technique used in to isolate a particular

protein from samples and quantify post-translational modifications of this
particular protein. The first step of IP is to incubate 250 µg of protein with the IP
buffer (0.05% NP-40, 4 µg/mL leupeptin, 4 µg/mL pepstatin, and 5 µg/mL
aprotinin in PBS; pH 8) shaking 30 min at 4 °C. In order to prevent non-specific
binding, samples were pre-cleaned with washed protein A/G-agarose beads (50
µL per sample) for 1 h at 4 °C. This procedure leas to removal of IgGs in the
samples. Supernatants were transferred to clean Eppendorf tubes after a 5 min
centrifugation in a Hettich Mikro 22 R microcentrifuge (Hettich, Beverly, MA) at
2500 rpm, 4 °C. Samples were incubated overnight with the antibody of interest.
In this study, anti-biliverdin reductase antibody was used to isolate biliverdin
reductase. Insoluble antigen-antibody-protein A/G complex was formed by the
addition of washed protein A/G-agarose beads and incubating for 1 h at 4 °C.
Subsequently the immunocomplex was centrifuged and the pellet was washed
five times with IP buffer (500 µL each time). Continuous shaking was used during
all incubation and washing steps. The pellet was suspended in DI water (20 µL)
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and 4X SDS-sample buffer (5 µL) followed by denaturation in boiling water for 5
min and cooled immediately on ice. The supernatants containing a particular
protein were ready for 1D-PAGE and Western blotting (see sections 3.6).
As described above, the nitrocellulose membrane was incubated with
primary anti-3NT and anti-HNE antibodies, respectively, followed by the
incubation of anti-rabbit IgG alkaline phosphatase secondary antibody to detect
the levels of specific protein oxidative modifications. Blots were developed with
BCIP/NBT color development substrate.
For analysis of phosphoserine and phospohthreonine beads, the
nitrocellulose membrane was incubated with primary anti-phosphoserine and
anti-phosphothreonine antibodies, respectively, followed by the incubation of
secondary anti-rabbit IgG horseradish peroxidase to assess the levels of specific
protein

phosphorylation

modifications.

Blots

were

developed

by

chemiluminescence techniques using ClarityTM Western ECL substrate. For
loading controls, the blots were first stripped by stripping solution. After washing
to remove the stripping solution, the blots were probed with primary anti-biliverdin
reductase antibody.
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①

Samples in IP buffer

1D gel & WB

Add antibody to form
antibody/antigen complexes
②

⑤

③

Discard supernatant

Add protein A/G-agarose beads

Wash antigen/antibody/
(protein A/G-agarose beads)
complexes
④

Figure 3.3 Immunoprecipitation procedure
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3.7.1

Identification of Protein Carbonyl Post-translational Modification
As for the detection of protein carbonyl modification of specific protein,

post-electrophoretic derivatization was used. The nitrocellulose membrane got
from immunoprecipitation and Western blotting was dried completely before
derivatization. In day 2, the membrane was first incubated in a solution consisting
of 80% TBS and 20% methanol for 5 min. The solution was changed to 2N HCl
and incubate for 5 min. The membrane was then incubated with 0.5mM 2,4dinitrophenylhydrazine (DNPH) in 2N HCl for exactly 5 min. After three 5 min
washes with 2N HCl and five 5 min washes with 50% methanol, the membrane
was then incubated with blocking solution. During all the incubation and washing
steps, continued shaking was applied at room temperature (Conrad, Talent et al.
2000). The following steps for membrane development were similar to the
detection of protein-bound carbonyls (see section 3.5.1.1).

3.8

Image analysis
All the blots were scanned using a ChemiDocTM MP Imaging System (Bio-

Rad, Hercules, CA) and quantified using Image Lab software. In order to prevent
slight difference in loading, bands intensities were normalized by the intensities
of loading control.

3.9

Statistical analysis
A Student’s t-test was used to compare the levels of oxidative stress,

expression of HO-1 and BVR, oxidative post-translational modifications of BVR,
and phosphorylation post-translational modifications of BVR in PINK1 knockout
mice and wild-type mice. P-values less than 0.05 were accepted as significant
different.
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Chapter 4.

4.1

Results

Oxidative stress levels in brain of PINK1 knockout mice compared to
age-matched control
PINK1-deficient brain has elevated oxidative stress. Protein carbonyls,

HNE, 3NT, as the widespread indicators of oxidative stress, were used to index
the effects of PINK1 knockout in brain.
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4.2

Protein carbonyl levels increase in PINK1 knockout mice compared
to age-matched control
Figure 4.1 shows protein carbonyl levels in the brains of PINK1 knockout

mice and age-matched control mice. The level of protein carbonyls was found to
be significantly increased in PINK1 knockout mice compared to age-matched
controls (P<0.002). This increase in protein carbonyl is approximately 13% higher
than control.

Figure 4.1 Protein carbonyl level in PINK1 knockout mice compared to agematched control mice.
PC level was measured using slot blot. Data are shown as % control. All the
values are expressed as mean ± SEM, wild type n=6, PINK1 knockout n=6. *P <
0.002.
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4.3

HNE-bound protein levels increase in brain of PINK1 knockout mice
compared to age-matched control
Figure 4.2 shows HNE-modified protein levels in the brains of PINK1

knockout mice and age-matched control mice. The level of HNE-bound protein
was found to be significantly increased in PINK1 knockout mice compared to
age-matched controls (P<0.02). This increase in protein-bound HNE is
approximately 14% higher than control.

Figure 4.2 HNE-bound protein level in PINK1 knockout mice compared to agematched control mice.
HNE level was measured using western blot technique. Tubulin was used as a
loading control to normalize the intensity of HNE-bound protein bands. Data are
shown as % control. All the values are expressed as mean ± SEM, wild type n=6,
PINK1 knockout n=6. *P < 0.02.
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4.4

Protein-3NT levels are unchanged in brain of PINK1 knockout mice
compared to age-matched control
Figure 4.3 shows 3-Nitrotyrosine levels in the brains of PINK1 knockout

mice and age-matched control mice. The level of 3-NT was not found to be
significantly changed in PINK1 knockout mice compared to age-matched controls.

Figure 4.3 3-NT resident protein level in PINK1 knockout mice compared to agematched control mice.
3-NT level was measured using slot blot. Data are shown as % control. All the
values are expressed as mean ± SEM, wild type n=6, PINK1 knockout n=6. No
significant differences were observed for PINK1 knockout mice.
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4.5

HO-1/BVR system levels in PINK1 knockout mice compared to agematched control
We previously have shown that PINK1 knockout causes increased

oxidative stress in brain. However, HO-1/BVR is an antioxidant system defense
against ROS or RNS stress. Therefore, we wanted to determine the effect of
oxidative stress on HO-1/BVR system. We measured the levels of HO-1 and
BVR in the brains of wild type mice and PINK1 knockout mice, respectively.
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4.6

HO-1 levels decrease slightly, but not statistically significant in brain
of PINK1 knockout mice compared to age-matched control
Figure 4.4 shows heme oxygenase-1 levels in the brains of PINK1

knockout mice and age-matched control mice. The level of HO-1 was not found
to be significantly changed in brain of PINK1 knockout mice compared to agematched controls.

HO-1
Tubulin
WT1

KO1

WT2

KO2

Figure 4.4 Heme Oxygenase-1 level in PINK1 knockout mice compared to agematched control mice.
HO-1 level was measured using western blot technique. Tubulin was used as a
loading control to normalize the intensity of HO-1 bands. Data are shown as %
control. All the values are expressed as mean ± SEM, wild type n=6, PINK1
knockout n=6. No significant differences were observed for PINK1 knockout mice.
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4.7

BVR levels increase in brain of PINK1 knockout mice compared to
age-matched control
Figure 4.5 shows biliverdin reductase levels in the brains of PINK1

knockout mice and age-matched control mice. The level of BVR was found to be
significantly increased in PINK1 knockout mice compared to age-matched
controls (P<0.03). This increase in BVR is approximately 14% higher than control.

BVR
Tubulin
WT1 KO1 WT2 KO2

Figure 4.5 Biliverdin Reductase level in PINK1 knockout mice compared to agematched control mice.
BVR level was measured using western blot technique. Tubulin was used as a
loading control to normalize the intensity of BVR bands. Data are shown as %
control. All the values are expressed as mean ± SEM, wild type n=6, PINK1
knockout n=6 Data are shown as % control. *P < 0.03.
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4.8

Levels of BVR oxidative post-translational modification in brain of
PINK1 knockout mice compared to age-matched control
In PINK1 knockout mice, heme oxygenase-1 levels did not change while

biliverdin reductase levels increased indicating that BVR plays a more important
role in response to oxidative stress. Therefore, we determined levels of BVR
oxidative post-translational modification.
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4.9

Protein carbonyl levels on BVR levels do not change in brain of
PINK1 knockout mice compared to age-matched control
Figure 4.6 shows protein carbonyl levels of biliverdin reductase in the

brains of PINK1 knockout mice and age-matched control mice. No apparent
differences in the intensity of PC of BVR was found between PINK1 knockout
mice and age-matched controls.

CO-BVR
BVR
WT1 KO1 WT2 KO2

Figure 4.6 Protein carbonyl of BVR level in PINK1 knockout mice compared to
age-matched control mice.
PC level was measured using immunoprecipitation. BVR was used as a loading
control to normalize the intensity of protein carbonyl on BVR bands. Data are
shown as % control. All the values are expressed as mean ± SEM, wild type n=6,
PINK1 knockout n=6. No significant differences were observed for PINK1
knockout mice.

38

4.10

Levels of HNE-bound BVR do not change in brain of PINK1 knockout
mice compared to age-matched control
Figure 4.7 illustrates HNE-bound biliverdin reductase levels in the brains

of PINK1 knockout mice and age-matched control mice. No apparent differences
in the intensity of HNE-bound BVR was found between PINK1 knockout mice
and age-matched controls.

HNE-BVR
BVR
WT1 KO1 WT2 KO2

Figure 4.7 HNE-bound BVR level in PINK1 knockout mice compared to agematched control mice.
HNE level was measured employing immunoprecipitation. BVR was used as a
loading control to normalize the intensity of HNE-bound BVR bands. Data are
shown as % control. All the values are expressed as mean ± SEM, wild type n=6,
PINK1 knockout n=6. No significant differences were observed for PINK1
knockout mice.
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4.11

Levels of 3NT on BVR do not change in brain of PINK1 knockout
mice compared to age-matched control
Figure 4.8 shows 3-NT of biliverdin reductase levels in the brains of PINK1

knockout mice and age-matched control mice. 3-NT of BVR did not show any
change between PINK1 knockout mice and age-matched controls.

3NT-BVR
BVR
WT1 KO1 WT2 KO2

Figure 4.8 3NT-bound BVR level in PINK1 knockout mice compared to agematched control mice.
3-NT level was measured employing immunoprecipitation. BVR was used as a
loading control to normalize the intensity of 3NT on BVR bands. Data are shown
as % control. All the values are expressed as mean ± SEM, wild type n=3, PINK1
knockout n=3. No significant differences were observed for PINK1 knockout mice.
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4.12

BVR phosphorylation post-translational modification levels in PINK1
knockout mice compared to age-matched control
Biliverdin reductase is an antioxidant enzyme as well as a serine/threonine

kinase. As Section 4.3 shows, oxidative post-translational modification of BVR
was inhibited, conceivably by its antioxidant function, i.e. by production of
bilirubin. In this section, we wanted to investigate whether the increase level of
BVR induce the change of BVR phosphorylation post-translational modification
levels.
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4.13

BVR phosphoserine levels significantly increase in brain of PINK1
knockout mice compared to age-matched control
Figure 4.9 shows biliverdin reductase phosphoserine levels in the brains

of PINK1 knockout mice and age-matched control mice. The level of BVR
phosphoserine was found to be significantly increased in PINK1 knockout mice
compared

to

age-matched

controls

(P<0.03).

This

increase

in

BVR

phosphoserine is approximately 90% higher than control.

Ser-BVR
BVR
WT1

KO1

WT2

KO2

Figure 4.9 BVR phosphoserine level in PINK1 knockout mice compared to agematched control mice.
BVR phosphoserine level was measured using immunoprecipitation. BVR was
used as a loading control to normalize the intensity of BVR phosphoserine bands.
Data are shown as % control. All the values are expressed as mean ± SEM, wild
type n=3, PINK1 knockout n=3. *P < 0.005.
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4.14

BVR phosphothreonine levels increase in brain of PINK1 knockout
mice compared to age-matched control
Figure 4.10 shows biliverdin reductase phosphothreonine levels in the

brains of PINK1 knockout mice and age-matched control mice. The level of BVR
phosphothreonine was found to be significantly increased in PINK1 knockout
mice compared to age-matched controls (P<0.05). This increase in BVR
phosphothreonine is approximately 31% higher than control.

Thr-BVR
BVR
WT1 KO1 WT2

KO2

Figure 4.10 BVR phosphothreonine level in PINK1 knockout mice compared to
age-matched control mice.
BVR phosphothreonine level was measured using immunoprecipitation. BVR
was used as a loading control to normalize the intensity of BVR
phosphothreonine bands. Data are shown as % control. All the values are
expressed as mean ± SEM, wild type n=3, PINK1 knockout n=3. *P < 0.05.
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Chapter 5.

Discussion

PINK1 is a gene that is linked to autosomal recessive familial Parkinson’s
disease (Varcin, Bentea et al. 2012). PINK1 functions as a serine/threonine
kinase as well as a protector of mitochondrial function. Mutation of the PINK1
gene contributes to the loss of mitochondrial protection against oxidative stress
(Moore, West et al. 2005). In fact, mitochondrial dysfunction plays a central role
in the pathogenesis of PD (Yao, Gandhi et al. 2011). Because of the function of
PINK1 protein, we expected two aspects of differences, oxidation and
phosphorylation, resulting from the loss of PINK1. This thesis research
investigated the effect of the defect of PINK1 on oxidative stress and heme
oxygenase-1/biliverdin

reductase

post-translational

modifications.

PINK1

knockout mouse is a genetic model of PD that used to study oxidative stress in
this thesis.
The dysfunction of mitochondria leads to ROS and oxidative stress. In PD,
oxidative stress contributes to the neurodegeneration (Andersen 2004). PINK1,
as a PD-related gene, may cause oxidative stress as well if it is mutated.
Oxidative stress contributes to the production of protein carbonyls, HNE, and 3NT. In this study, significant increased levels of protein carbonyls and HNE were
observed in PINK1 knockout mice compared to control mice. These results are
consistent with our hypothesis that oxidative stress is elevated in the brain of
PINK1 knockout mice. In contrast, however, previous studies reported
unchanged levels of protein carbonyls and HNE-bound proteins in different parts
of the brain of PINK1 knockout mice at 24 months (Gautier, Kitada et al. 2008). It
is possible that the time for sample homogenization in this work differs from the
one reported in the literature. Longer preparation time would increase free
radicals in the samples. Additionally, the level of 3-NT bound protein given by
present data did not show any apparent change.
In order to prevent cellular impairment, antioxidant systems have been
considered to respond to the up-regulated oxidative stress. The heme
oxygenase-1/Biliverdin reductase system is such an example. Biliverdin
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reductase reduces biliverdin, the product of heme degraded by heme oxygenase1, to the antioxidant bilirubin. To determine if the increase in oxidative stress
levels observed in PINK1 knockout mice were related to the HO-1/BVR system,
HO-1 and BVR protein expression were measured, respectively. It is unclear how
the HO-1/BVR system functions in Parkinson’s disease to date, even though it
has been studied well in Alzheimer disease (Barone, Di Domenico et al. 2011,
Barone, Di Domenico et al. 2011, Barone, Di Domenico et al. 2014). The current
results, for the first time, report that the level of BVR was significantly increased
in PINK1 knockout mice. The increased of BVR rather than HO-1 indicates that
the terminal product of this system, bilirubin, becomes more efficient to scavenge
ROS. Recent studies showed the conversion from heme to biliverdin by heme
oxygenase-1 is not always neuro-protective. A product of this reaction, iron (II),
can cause free radicals by Fenton chemistry and subsequently initiate oxidative
stress (Gutteridge, Maidt et al. 1990). Moreover, HO-1 level in the substantia
nigra neurons of PD and control cases are similar (Schipper 2000). PINK1
knockout, as a model of PD, presents similar results as in our study. However, a
significant increase in BVR protein level promotes its ability to keep cellular
homeostasis.
Furthermore, we chose to investigate the post-translational modifications
of BVR for the following experiments because of its elevated ability to combat
oxidative stress as shown in this thesis research. Previous work leads to the
hypothesis that oxidative modification of BVR may decrease. The current results
obtained from immunoprecipitation technique showed similar levels of protein
carbonyls, HNE, and 3-NT of BVR in both PINK1 knockout mice and controls
mice. These results are in accordance with the hypothesis that high levels of
BVR are efficient to keep oxidative modification of BVR back to normal level.
Another novel finding of this thesis research is the change of
phosphorylation modification of BVR in PINK1 knockout mice. Since PINK1
serves as a serine/threonine kinase, phosphorylation of BVR may be changed if
PINK1

gene

is

deficient.

On

the
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other

hand,

BVR

is

capable

of

autophosphorylation, and phosphorylation is important for its activation (Salim,
Brown-Kipphut et al. 2001). Serine and threonine are the targets for BVR
phosphorylation. The data presented in this research demonstrated significant
increased BVR phosphoserine and phosphothreonine in PINK1 knockout mice
brain with respect to controls. These results provided another reasonable
explanation for the previous work showing up-regulation of BVR activated by the
increased phosphorylation. Based on Fabio Di Domenico’s work (Di Domenico,
Perluigi et al. 2013), we may speculate that activated BVR together with
increased production of antioxidant is able to keep nitric oxide levels under
control. Therefore, even elevated NOS levels result from PINK1 knockout will not
cause higher nitrosative stress levels. However, further studies are needed to
confirm this hypothesis. Interestingly, these results, in contrast, show increased
BVR phosphorylation together with deficient PINK1 kinase. A possible
interpretation is that PINK1 protein, as a kinase, does not regulate BVR
phosphorylation directly. This notion will be the subject of future studies from our
laboratory.
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Chapter 6.

Conclusion and Future Studies

In conclusion, the work presented in this thesis showed the presence of
oxidative stress along with the alternation of BVR post-translational modification
in the brain of PINK1 knockout mice. Specifically, we examined levels of protein
carbonyls, HNE-bound proteins, and nitrated proteins. The results established a
relationship between oxidative stress and the mice brain with PINK1
abnormalities. The notion that antioxidant system makes a response to oxidative
stress has been demonstrated by the up-regulated levels of BVR. With regard to
BVR post-translational modification, we observed an unchanged level of
oxidative translational modification along with significant increase in Ser-residue
and

Thr-residue

phosphorylation,

which

demonstrated

antioxidant

and

autophosphorylation abilities of BVR in the brain of PINK1 knockout mice. We
first reported the characterization of HO-1/BVR system in PINK1 knockout mice
which has been only studied with respect to Alzheimer disease to date, providing
a new perspective of treatment of Parkinson’s disease.
Based on the results in this thesis, we may be concern about the following
experiments for future studies:
1. BVR has been found involved in insulin signaling pathway. It is a substrate
for insulin receptor as well as a kinase for insulin receptor kinase,
regulating MAPK and PI3K cascades. The findings of up-regulated levels
of BVR and alternation of phosphorylation of BVR in PINK1 knockout mice
may indicate its possible role in insulin receptor system. Therefore, it will
be meaningful to investigate whether cell signal function of BVR changed
in PINK1 deficiency cells.
2. Determine the level of nitric oxide synthase, which verifies the speculation
that activated BVR keeps protein 3-NT levels in normal.
3. Determine whether PINK1 protein, as a kinase, regulates BVR
phosphorylation directly or not.
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Appendix: Data to Supplement Figures
Figure 4.1 Protein carbonyl levels
Wildtype Knockout
6823135 8908625
6275115 8637365
7829250 7157315
6759170 7260220
7151485 8443655
8013335 8376885
Average 7141915 8130678
%Control

Average
Std Dev
SEM

95.54
87.86
109.62
94.64
100.13
112.20
100.00
8.54
3.49
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124.74
120.94
100.22
101.66
118.23
117.29
113.84
9.44
3.85

Figure 4.2 Protein-bound HNE levels
Wildtype

Knockout

34907999
37492364
35837672
34825302
34725652
37958856
Tubulin
46031927
40305920
36999128
40106885
39598381
44750475
HNE/Tubulin
0.758
0.93
0.969
0.868
0.877
0.848
Average
0.875

40400364
39958416
32791518
37018140
36654780
42221274
41935731
35982408
34531368
38904120
37568073
39060360
0.963
1.11
0.95
0.952
0.976
1.081
1.005

HNE

%Control

Average
Std Dev
SEM

86.66
106.3
110.68
99.22
100.21
96.93
100
8.27
3.38
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110.09
126.9
108.51
108.73
111.49
123.52
114.87
8.15
3.33

Figure 4.3 Protein-3NT levels

3-NT

Tubulin

3-NT/Tubulin

Average
%Control

Average
Std Dev
SEM

Wildtype

Knockout

45019512
51666336
52212384
50711544
48658968
50685984
39980162
35791371
36876224
39662546
43543962
41674556
1.13
1.44
1.42
1.28
1.12
1.22
1.27

46365264
51932592
43072632
45826776
46948320
44181144
36624280
39364325
35965853
40425693
39682489
43997800
1.27
1.32
1.2
1.13
1.18
1
1.18

88.92
114
111.81
100.97
88.25
96.05
100
11.07
4.52

99.97
104.18
94.58
89.52
93.43
79.3
93.5
8.66
3.53

50

Figure 4.4 Heme Oxygenase-1 levels

HO-1

Tubulin

HO1/Tubulin

Average
%Control

Average
Std Dev
SEM

Wildtype

Knockout

1139502
1351896
1119924
1309776
1327404
1110330
53901542
41292636
41881779
44186552
50727465
48209025

1021488
1002456
1119300
1273584
1217424
994578
46671750
44621192
41300625
45388112
49461742
51953671

2.11E-02

2.19E-02

3.27E-02
2.67E-02
2.96E-02
2.62E-02
2.30E-02
2.66E-02

2.25E-02
2.71E-02
2.81E-02
2.46E-02
1.91E-02
2.39E-02

79.54
123.19
100.61
111.53
98.46
86.66
100
15.94
6.51

82.35
84.53
101.97
105.58
92.61
72.03
89.85
12.68
5.18
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Figure 4.5 Biliverdin Reductase levels
Wildtype
BVR

520191
610650
672543
637146
583326
650118
Tubulin
47594448
42192780
42309280
49431120
44433732
41476400
BVR/Tubulin 1.09E-02
1.45E-02
1.59E-02
1.29E-02
1.31E-02
1.57E-02
Average
1.38E-02
%Control

Average
Std Dev
SEM

79.02
104.64
114.92
93.19
94.91
113.32
100
13.67
5.58
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Knockout
672543
709389
630936
650739
718428
43322240
43832000
42683120
39930480
43680000
1.55E-02
1.62E-02
1.48E-02
1.63E-02
1.64E-02
1.58E-02
112.24
117.01
106.87
117.82
118.91
114.57
5
2.04

Figure 4.6 Protein carbonyl on BVR levels

Average

Wildtype
16029778
12708059
15736610
18416659
13408129
14260185
401147
387543
521683
750063
371792
370215
39.96
32.79
30.17
24.55
36.06
38.52
33.68

Knockout
21038308
14937260
20837193
18730121
17738197
20781713
1207716
656469
528238
397195
715616
698915
17.42
22.75
39.45
47.16
24.79
29.73
30.22

%Control

118.66

51.73

Average
Std Dev
SEM

97.38
89.58
72.91
107.09
114.38
100
17.06
6.96

67.57
117.14
140.03
73.61
88.3
89.73
33.1
13.51

PC

BVR

PC/BVR
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Figure 4.7 Levels HNE-bound BVR
Wildtype
HNE
14336397
16564065
17595701
15458559
12427050
15956206
BVR
10769700
14331360
17611853
12054189
8988501
12228438
HNE/BVR
1.33
1.16
1
1.28
1.38
1.3
Average
1.24

Knockout
17455541
22703803
16705104
13785034
14810996
17532588
15236925
20543925
18666900
13601967
8221908
11267703
1.15
1.11
0.89
1.01
1.16
1.56
1.15

%Control

107.12

92.19

Average
Std Dev
SEM

93.01
80.4
103.2
111.26
105.01
100
11.37
4.64

88.93
72.02
81.56
93.06
125.22
92.16
18.01
7.35
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Figure 4.8 Levels of 3NT on BVR
Wildtype
3NT
3018525
4056150
5465925
BVR
10769700
14331360
17611853
3NT/BVR 2.80E-01
2.83E-01
3.10E-01
Average 2.91E-01
%Control

Average
Std Dev
SEM

96.24
97.19
106.57
100
5.71
3.3
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Knockout
4353600
5238450
5299520
15236925
20543925
18666900
2.86E-01
2.55E-01
2.84E-01
2.75E-01
98.11
87.56
97.49
94.39
5.92
3.42

Figure 4.9 BVR phosphoserine levels
Ser

BVR

Ser/BVR

Average
%Control

Average
Std Dev
SEM

Wildtype
20574264
22601488
20813664
12768528
11819556
10791844
1.61
1.91
1.93
1.82

Knockout
13354948
17261880
11428044
3753604
6156662
3550182
3.56
2.8
3.22
3.19

88.66
105.22
106.12
100
9.83
5.68

195.77
154.27
177.12
175.72
20.78
12
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Figure 4.10 BVR phosphothreonine levels
Thr

BVR

Thr/BVR

Average
%Control

Average
Std Dev
SEM

Wildtype
19667625
21120890
23647960
10683512
13345992
17053968
1.84
1.58
1.39
1.6

Knockout
24868690
22653820
23021740
11333476
10113440
12339876
2.19
2.24
1.87
2.1

114.82
98.7
86.48
100
14.21
8.2

136.85
139.7
116.36
130.97
12.74
7.35
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